Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461

Ann Hematol. 2004:83 Suppl 1:S84-5. doi: 10.1007/s00277-004-0850-2.
No abstract available

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Antimetabolites, Antineoplastic / therapeutic use
  • Chromosomes, Human, Pair 21 / genetics
  • Chromosomes, Human, Pair 8 / genetics
  • Core Binding Factor Alpha 2 Subunit
  • Cytarabine / therapeutic use
  • DNA-Binding Proteins / genetics*
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy
  • Leukemia, Myeloid, Acute / genetics*
  • Neoplasms / drug therapy
  • Neoplasms / genetics
  • Proto-Oncogene Proteins / genetics*
  • Transcription Factors / genetics*
  • Translocation, Genetic

Substances

  • Antimetabolites, Antineoplastic
  • Core Binding Factor Alpha 2 Subunit
  • DNA-Binding Proteins
  • Proto-Oncogene Proteins
  • RUNX1 protein, human
  • Transcription Factors
  • Cytarabine